Scale and Spread of a Quality Improvement Initiative Promoting Metronidazole Intravenous to Oral Switch (IVOST) in the Acute Hospital Setting: Antimicrobial Stewardship, Patient Safety, Workforce and Environmental Sustainability Benefits

Case study: SusQI

The aim of this study was to scale and spread a quality improvement (QI) initiative promoting appropriate intravenous to oral switch (IVOST) of metronidazole in all adult inpatient wards in NHSGGC Clyde hospitals (Royal Alexandra Hospital, Inverclyde Royal Hospital and Vale of Leven Hospital) and measure the impact on antimicrobial stewardship (AMS), drug costs, nursing workload and environmental sustainability.

Resource author(s)

Rachael Rodger, Amy Robertson, Emma Thompson, Karen Downie, Sharon Thompson, Gautam Ray, Lindsey Chisholm and Rosie Hillson

Resource publishing organisation(s) or journal

JAC-Antimicrobial Resistance

Resource publication date

July 2024

Visit resource

Download resource - SusQI Project Report Template Metronidazole QI NHSGGC Clyde 2024.pdf

Scale and Spread of a Quality Improvement Initiative Promoting Metronidazole Intravenous to Oral Switch (IVOST) in the Acute Hospital Setting: Antimicrobial Stewardship, Patient Safety, Workforce and Environmental Sustainability Benefits

Be the first one to comment